Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Fingolimod induces neuroprotective factors in human astrocytes.
Contribution of MicroRNAs to autoimmune diseases.
Ten-year follow-up shows efficacy of Sanofi's MS drug Lemtrada
Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM.
[Processing speed in relapsing-remitting multiple sclerosis: the role played by the depressive symptoms].
Polyphenols: multipotent therapeutic agents in neurodegenerative diseases.
Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis.
Frequency and economic impact of comorbid cardiac conditions with multiple sclerosis.
Interplaying factors that effect multiple sclerosis causation and sustenance.
MS Patients Report Excellent Compliance with Oral Prednisone for Acute Relapses.
Viruses and Multiple Sclerosis.
Therapeutic effet of phase ii enzyme inducers in experimental allergic encephalomyelitis (eae).
Deficiency of prolyl oligopeptidase in mice disturbs synaptic plasticity and reduces anxiety-like behaviour, body weight, and brain volume.
Minocycline attenuates iron neurotoxicity in cortical cell cultures.
A randomized clinical trial of autologous T-cell therapy in multiple sclerosis: subset analysis and implications for trial design.
Cystoid macular oedema after fingolimod treatment in multiple sclerosis.
Poster abstracts from the third international symposium on gait and balance in multiple sclerosis: selecting the right measures.
The effects of aquatic therapy on mobility of individuals with neurological diseases: A systematic review.
Cannabis-based medicines in multiple sclerosis--a review of clinical studies.
Iron in multiple sclerosis: roles in neurodegeneration and repair.
[Change of treatment in patients with multiple sclerosis and its consequences in clinical practice].
Validity and reliability of Persian version of Modified Fatigue Impact Scale (MFIS) questionnaire in Iranian patients with multiple sclerosis.
Development and initial validation of the Perceptions of Parental Illness Questionnaire (PPIQ).
UDP-glucose enhances outward K(+) currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors.
Commentary on "Possible induction of acute disseminated encephalomyelitis (ADEM)-like demyelinating illness by intrathecal mesenchymal stem cell injection"

Pages